CLINICAL AND DIAGNOSTIC SIGNIFICANCE OF MOLECULAR MARKERS IN POTENTIALLY PREMALIGNANT ORAL LESIONS

Authors

  • Kamilov Kh.P DSc, professor
  • Kakhkharova D.J DSc, associate professor
  • Gulyamova M.R MSc, Tashkent State Medical University

Abstract

Meta-analysis of 18 scientific research including 264 people diagnosed with oral premalignant lesions (PML), malignant lesions (ML) and normal mucosa (NM) was carried out. The obtained information was summarized with outlines presented below.

References

1. Mello FW, Melo G, Guerra ENS, Warnakulasuriya S, Garnis C, Rivero ERC.Oral potentially malignant disorders: A scoping review of prognostic biomarkers. Oral Oncology. 2020;105:104668.

2. Ramos-García P, González-Moles MÁ, Warnakulasuriya S. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis. Oral Oncology. 2022;126:105764.

3. Khan S, et al. Immunohistochemical Expression of MCM-2 in Oral Epithelial Dysplasias. Journal of Clinical and Diagnostic Research. 2016.

Downloads

Published

2026-09-12

How to Cite

Kamilov Kh.P, Kakhkharova D.J, & Gulyamova M.R. (2026). CLINICAL AND DIAGNOSTIC SIGNIFICANCE OF MOLECULAR MARKERS IN POTENTIALLY PREMALIGNANT ORAL LESIONS. NEW APPROACHES IN EDUCATION: PEDAGOGY, INNOVATION, AND DEVELOPMENT, 2(09), 35–36. Retrieved from https://worldconferences.us/index.php/nae/article/view/1620